# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-108601
Filing Date
2023-10-11
Accepted
2023-10-11 17:14:42
Documents
43
Period of Report
2023-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2328076d1_8k.htm iXBRL | 8-K | 45224
2 | EXHIBIT 99.1 | tm2328076d1_ex99-1.htm | EX-99.1 | 20119
3 | EXHIBIT 99.2 | tm2328076d1_ex99-2.htm | EX-99.2 | 48276
7 | GRAPHIC | tm2328076d1_ex99-1img001.jpg | GRAPHIC | 14337
8 | GRAPHIC | tm28076d1_ex99-2img001.jpg | GRAPHIC | 155031
9 | GRAPHIC | tm28076d1_ex99-2img002.jpg | GRAPHIC | 381821
10 | GRAPHIC | tm28076d1_ex99-2img003.jpg | GRAPHIC | 86425
11 | GRAPHIC | tm28076d1_ex99-2img004.jpg | GRAPHIC | 158297
12 | GRAPHIC | tm28076d1_ex99-2img005.jpg | GRAPHIC | 284498
13 | GRAPHIC | tm28076d1_ex99-2img006.jpg | GRAPHIC | 159846
14 | GRAPHIC | tm28076d1_ex99-2img007.jpg | GRAPHIC | 220207
15 | GRAPHIC | tm28076d1_ex99-2img008.jpg | GRAPHIC | 159974
16 | GRAPHIC | tm28076d1_ex99-2img009.jpg | GRAPHIC | 555874
17 | GRAPHIC | tm28076d1_ex99-2img010.jpg | GRAPHIC | 169062
18 | GRAPHIC | tm28076d1_ex99-2img011.jpg | GRAPHIC | 229289
19 | GRAPHIC | tm28076d1_ex99-2img012.jpg | GRAPHIC | 166511
20 | GRAPHIC | tm28076d1_ex99-2img013.jpg | GRAPHIC | 239321
21 | GRAPHIC | tm28076d1_ex99-2img014.jpg | GRAPHIC | 213896
22 | GRAPHIC | tm28076d1_ex99-2img015.jpg | GRAPHIC | 339204
23 | GRAPHIC | tm28076d1_ex99-2img016.jpg | GRAPHIC | 195256
24 | GRAPHIC | tm28076d1_ex99-2img017.jpg | GRAPHIC | 170341
25 | GRAPHIC | tm28076d1_ex99-2img018.jpg | GRAPHIC | 290774
26 | GRAPHIC | tm28076d1_ex99-2img019.jpg | GRAPHIC | 106640
27 | GRAPHIC | tm28076d1_ex99-2img020.jpg | GRAPHIC | 150117
28 | GRAPHIC | tm28076d1_ex99-2img021.jpg | GRAPHIC | 192795
29 | GRAPHIC | tm28076d1_ex99-2img022.jpg | GRAPHIC | 203847
30 | GRAPHIC | tm28076d1_ex99-2img023.jpg | GRAPHIC | 174693
31 | GRAPHIC | tm28076d1_ex99-2img024.jpg | GRAPHIC | 174257
32 | GRAPHIC | tm28076d1_ex99-2img025.jpg | GRAPHIC | 182101
33 | GRAPHIC | tm28076d1_ex99-2img026.jpg | GRAPHIC | 174336
34 | GRAPHIC | tm28076d1_ex99-2img027.jpg | GRAPHIC | 266667
35 | GRAPHIC | tm28076d1_ex99-2img028.jpg | GRAPHIC | 66048
| Complete submission text file | 0001104659-23-108601.txt |  | 8409272

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | atxs-20231004.xsd | EX-101.SCH | 3018
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | atxs-20231004_lab.xml | EX-101.LAB | 34240
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | atxs-20231004_pre.xml | EX-101.PRE | 22361
37 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2328076d1_8k_htm.xml | XML | 3321

Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 231321318
SIC: 2834 Pharmaceutical Preparations